FCM
CO

Farallon Capital Management’s Global Cord Blood Corporation CO Stock Holding History

Farallon Capital Management’s Portfolio CO Stock Details CO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-404,850
Closed -$2.44M – 85
2015
Q3 		$2.44M Buy
+404,850
New +$2.52M 0.03% 75

Other funds holding CO

Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
GP
GLG Partners London, United Kingdom $2.14B AUM 21.14% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
PG
PEAK6 Group Chicago, Illinois $23.4B AUM 17.65% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
PAM
Panagora Asset Management Boston, Massachusetts $26.7B AUM 36.4% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Farallon Capital Management's CO Position: Q4 2015 in Review

Farallon Capital Management sold out of Global Cord Blood Corporation (CO) in Q4 2015, closing a stake of 404,850 shares — an estimated $2.44M sold.

Farallon Capital Management first reported a position in CO in Q3 2015 and held it in 1 quarter. The position peaked at $2.44M in Q3 2015. 35 funds tracked by Wall St. Rank hold CO as of Q4 2015.

  • Farallon Capital Management reported no remaining Global Cord Blood Corporation position as of Q4 2015 after selling out during the quarter.
  • Farallon Capital Management sold 404,850 Global Cord Blood Corporation shares in Q4 2015, an estimated $2.44M.
  • Farallon Capital Management first reported a position in Global Cord Blood Corporation in Q3 2015 and held it in 1 quarter.
  • Farallon Capital Management's Global Cord Blood Corporation position peaked at $2.44M in Q3 2015.
  • 35 funds tracked by Wall St. Rank held Global Cord Blood Corporation as of Q4 2015.

Based on Farallon Capital Management's 13F filing for Q4 2015, filed 16 Feb 2016.